메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한신경과학회 Journal of Clinical Neurology Journal of Clinical Neurology 제14권 제2호
발행연도
2018.1
수록면
186 - 190 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Purpose Patients treated with interferon-beta (IFN-β) can develop neutralizingantibodies (NAbs) against IFN-β that can negatively affect the therapeutic response. This study assessed the prevalence of NAbs and the impact of NAb positivity on the therapeuticresponse to IFN-β in Korean patients with multiple sclerosis (MS). Methods This was a multicenter study involving 150 MS patients from 9 Korean medicalcenters who were treated with IFN-β for at least 6 months. Sera that had not been influencedby acute treatment were assessed for NAbs using a luciferase reporter gene assay. To evaluatethe association between persistent positivity for NAbs and disease activity, NAbs were tested at2 different time points in 75 of the 150 patients. Disease activity was defined as the presence ofclinical exacerbations and/or active MRI lesions during a 1-year follow-up after NAb positivitywas confirmed. Results NAbs were found in 39 of the 150 (26%) MS patients: 30 of the 85 (35%) who weretreated with subcutaneous IFN-β-1b, 9 of the 60 (15%) who were treated with subcutaneousIFN-β-1a, and 0 of the 5 (0%) who were treated with intramuscular IFN-β-1a. Thirty of the 39patients exhibiting NAb positivity were tested at different time points, and 20 of them exhibitedpersistent NAb positivity. Disease activity was observed more frequently in patients with persistentNAb positivity than in those with transient positivity or persistent negativity [16/20 (80%)vs. 4/55 (7%), respectively; p<0.001]. When disease activity was compared between patientswith persistent and transient NAb positivity, the difference was unchanged and remained statisticallysignificant [16/20 (80%) vs. 2/10 (20%), p=0.004]. Conclusions These results further support that persistent NAb positivity is associated withdisease activity in MS patients treated with IFN-β.

목차

등록된 정보가 없습니다.

참고문헌 (27)

참고문헌 신청
The IFNB Multiple Sclerosis Study Group / 1993 / Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial / Neurology 43:655~661 Crossref Deisenhammer F / 2009 / Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes / CNS Drugs 23:379~396 Crossref Sorensen PS / 2005 / Appearance and disappearance of neutralizing antibodies during interferon-beta therapy / Neurology 65:33~39 Crossref Rudick RA / 1998 / Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) / Neurology 50:1266~1272 Crossref Francis GS / 2005 / Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMS / Neurology 65:48~55 Crossref

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0